Return to Article Details NINTEDANIB HAD CONSISTENT EFFECT ON SLOWING THE RATE OF DECLINE OF FORCED VITAL CAPACITY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND OTHER PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES, AND WITH SYSTEMIC SCLEROSIS-ASSOCIATED LUNG DISEASE Download Download PDF